Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $54.2 million.

  • Accendra Health's Capital Expenditures fell 590.61% to $54.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.7 million, marking a year-over-year increase of 2128.48%. This contributed to the annual value of $210.9 million for FY2024, which is 1047.57% up from last year.
  • Accendra Health's Capital Expenditures amounted to $54.2 million in Q3 2025, which was down 590.61% from $114.6 million recorded in Q2 2025.
  • Over the past 5 years, Accendra Health's Capital Expenditures peaked at $114.6 million during Q2 2025, and registered a low of $3.4 million during Q1 2024.
  • In the last 5 years, Accendra Health's Capital Expenditures had a median value of $47.0 million in 2022 and averaged $41.0 million.
  • In the last 5 years, Accendra Health's Capital Expenditures skyrocketed by 44922.77% in 2022 and then plummeted by 9260.89% in 2024.
  • Accendra Health's Capital Expenditures (Quarter) stood at $14.5 million in 2021, then surged by 235.75% to $48.8 million in 2022, then grew by 3.23% to $50.4 million in 2023, then grew by 24.69% to $62.8 million in 2024, then dropped by 13.67% to $54.2 million in 2025.
  • Its last three reported values are $54.2 million in Q3 2025, $114.6 million for Q2 2025, and $9.0 million during Q1 2025.